Autoradiographic assessment of SynVesT-1 revealed changes in non-displaceable binding with demyelination and remyelination: implications for SV2A PET analysis [0.03%]
SynVesT-1的自显影评估显示，随着脱髓鞘和再髓鞘化而非置换结合力发生了变化：对SV2A正电子发射断层扫描分析的意义
Pantila Panichnantakul,Robert C Shaw,Valeria K Burianova et al.
Pantila Panichnantakul et al.
Preliminary study of FAP-targeted radiopharmaceuticals based on covalent targeting strategy and pharmacokinetic characteristics [0.03%]
基于共价连接策略和药代动力学特征的FAP靶向放射性药物的初步研究
Yiheng Ai,Zhongcai Jin,Tongtong Wu et al.
Yiheng Ai et al.
Assessing vascular inflammation during continuous TSH suppression in differentiated thyroid cancer: a longitudinal [18F]FDG PET/CT analysis [0.03%]
持续TSH抑制对分化型甲状腺癌血管炎症的评估：纵向[18F]FDG PET/CT分析
Holger Einspieler,Bengt Hennig,Hannah Klimpfinger et al.
Holger Einspieler et al.
ImmunoPET with Zirconium-89 specifically detects postoperative biofilm-associated implant infections: a preclinical study [0.03%]
一种基于免疫的PET显像术能用锆-89来特异性检测与术后生物膜相关的移植物感染：一项临床前研究
F Ruben H A Nurmohamed,Kevin J H Allen,Connor Frank et al.
F Ruben H A Nurmohamed et al.
[18F]FDG WBC labelled PET/CT for the diagnosis of infectious disease: initial experience in a tertiary centre [0.03%]
[18F]FDG标记的白细胞正电子发射型计算机断层扫描/X线计算机体层成像诊断感染性疾病的价值：一家三级医疗机构的初步研究
Christel Hermann Kamani,Julien Costes,Maxime Panchaud et al.
Christel Hermann Kamani et al.
Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE [0.03%]
放射性药物治疗中健康组织的临床前体内剂量学：在GATE中实现生理现实的小鼠眼睛模型
Elodie Jouberton,Nicolas Sas,Tommy Billoux et al.
Elodie Jouberton et al.
Enhanced in-vivo persistence and PET imaging performance of [68Ga]Ga-DOTA-TMVP1446/GS5 as a VEGFR-3 radiotracer [0.03%]
一种VEGFR-3示踪剂[68Ga]Ga-DOTA-TMVP1446/GS5的体内持久性增强及PET显像性能研究
Jing Wang,Xi Chen,Sixuan Cheng et al.
Jing Wang et al.
Background: Vascular endothelial growth factor receptor-3 (VEGFR-3) is overexpressed in tumor-induced lymphangiogenesis. TMVP1446/GS5 is a peptide analogue specifically targeting VEGFR-3, developed through substitution of...
Biodistribution, radiodosimetry and pharmacokinetics of [18F]GSK1482160 for cerebral P2X7 receptor in living subjects [0.03%]
[18F]GSK1482160在活体内的生物分布、放射剂量学和药代动力学用于检测脑P2X7受体
Lei Bi,Kun He,Lu Wang et al.
Lei Bi et al.
FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery [0.03%]
FAPi-PET/CT作为亚临床心肌纤维化的替代标志物可作为接受左心瓣膜手术患者的预后工具
Theresa Holst,Alexander Dierks,Marianne Patt et al.
Theresa Holst et al.
Background: The aim of this study was to evaluate fibroblast activation protein (FAP)-targeted positron emission tomography and computed tomography (PET/CT) imaging as surrogate marker for cardiac fibrosis and therefore a...
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D [0.03%]
使用高级细胞模型进行靶向放射性核素治疗评估：与二维相比，三维的疗效增强
Maria J Klomp,Sigrun E Erkens,Lilian van den Brink et al.
Maria J Klomp et al.
Background: Preclinically, radiopharmaceuticals are currently mainly evaluated in two-dimensional (2D) cell models, which lack clinical features that are relevant for accurate evaluation of targeted radionuclide therapy (...